News and Trends 22 Jun 2017 Novartis Scores Major Phase III Win with New Cardiovascular Drug …events (MACE), a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, in patients with a prior heart attack and inflammatory atherosclerosis. While a detailed analysis of the top-line… June 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 3 May 2023 Immunotherapy in the fight against solid tumors …works by blocking checkpoint proteins from binding with their partner proteins on tumor cells, which prevents an ‘off’ signal from being sent to the T cells, thereby allowing them to… May 3, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2019 This Retinal Implant Lets Visually-Impaired Patients See Patterns …shown no serious adverse events in any of the patients until now. A larger European pivotal study in around 50 patients is the next step for Pixium. By 2022, the… January 10, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 OncoBone signs deals with three partners to work on bone metastases …can cause problems such as pain, broken bones, or more serious events. Almost all cancers can spread to the bone. Cancers that often spread there include breast, lung, prostate, kidney,… September 8, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2022 Regeneron and Sanofi announce published trial results in children with dermatitis …profile in patients 6 years and older with atopic dermatitis. Adverse events that were more commonly observed with Dupixent – at 5% or less included conjunctivitis, herpes viral infections, molluscum… September 16, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2017 Swedish Oncology Biotech Teams up with World Leading Cancer Center …major role in human cancer and is mutated in more than 50% of all tumors. In normal cells, p53 induces a cascade of events leading to cell death in response… March 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Jun 2019 The Top 20 Industrial Biotechnology Companies in Europe …the Danish Aerospace Company. Biomimetx Founded: 2013 Location: Lisbon, Portugal Conveniently located near the sea, Biomimetx develops an anti-fouling paint additive that prevents microorganisms from latching onto and growing on… June 19, 2019 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2022 Beckley Psytech completes treatment resistant depression and alcohol use disorder study …and 12mg or a placebo. Initial results showed a dose-proportional pharmacokinetic (PK) profile and good tolerability with no serious adverse events reported. BPL-003 demonstrated rapid onset of effect within minutes… November 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jun 2020 Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B …a particularly difficult target for drugs of all kinds due to the blood-brain barrier, which prevents molecules in the blood from entering the brain. Exosomes could be one way to… June 11, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2016 UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug …who were inadequate responders to TNF-alpha inhibitors took part, with promising results. However, treatment-emergent adverse events (TEAEs) in the drug reception included infection (ranging from 22 – 30% across the… October 31, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2022 NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders …inhibition of the mPTP in the brain prevents neuronal cell death, reduces neuroinflammation and extends survival in animals. We look forward to working with Domainex to progress the development of these… June 30, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Opinion 11 Jul 2022 Precision medicine: the next big leap for metabolic disorders …metabolic disorders, different therapeutic strategies are also needed for each patient endotype. Precision medicine prevents the waste of healthcare resources on treating patients with sub-optimal medications, which can increase their… July 11, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email